An immediate transcriptional signature predicts response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts

ABSTRACT: Gene expression analysis of three sets of patient-derived T-ALL xenografted murine lines treated or not treated with Givinostat, to investigate the immediate anti-leukemic effects after 6 hours of in vivo treatment with this histone deacetylase inhibitor.

ORGANISM(S): Homo sapiens

PROVIDER: GSE69346 | GEO | 2015/09/30

SECONDARY ACCESSION(S): PRJNA285332

REPOSITORIES: GEO